Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.16T
Market cap1.16T
Price-Earnings ratio
40.36
Price-Earnings ratio40.36
Dividend yield
0.58%
Dividend yield0.58%
Average volume
2.94M
Average volume2.94M
High today
$1,230.88
High today$1,230.88
Low today
$1,178.10
Low today$1,178.10
Open price
$1,197.99
Open price$1,197.99
Volume
858.62K
Volume858.62K
52 Week high
$1,249.45
52 Week high$1,249.45
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,180.48, giving the company a market capitalization of 1.16T. It carries a P/E multiple of 40.36 and pays a dividend yield of 0.58%.

On 2026-08-06, Eli Lilly(LLY) stock traded between a low of $1,178.10 and a high of $1,230.88. Shares are currently priced at $1,180.48, which is +0.2% above the low and -4.1% below the high.

The Eli Lilly(LLY)'s current trading volume is 858.62K, compared to an average daily volume of 2.94M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.

LLY News

CNBC 44m
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

Key Points Both Eli Lilly and Novo Nordisk beat second-quarter estimates and raised their full-year outlooks. But while investors cheered Lilly's results, they...

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
TipRanks 3h
Eli Lilly price target raised to $1,419 from $1,347 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Eli Lilly (LLY) to $1,419 from $1,347 and keeps an Overweight rating on the shares. The firm views Lilly’s Q2 r...

Seeking Alpha 4h
Amazon delivers GLP-1s for $50 per month for Medicare recipients

Amazon Pharmacy (AMZN) has joined a federal program to offer GLP-1 weight-loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) to eligible Medicare enrollees...

Amazon delivers GLP-1s for $50 per month for Medicare recipients

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
12.9%
Sell
6.5%

More LLY News

TipRanks 4h
Michael Yee Reiterates Buy Rating and Maintains $1,425 Price Target on Strong Earnings Power and Obesity Portfolio Momentum

Analyst Michael Yee from UBS maintained a Buy rating on Eli Lilly & Co and keeping the price target at $1,425.00. Unlock powerful investing tools with TipRanks...

The Wall Street Journal 4h
Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk
Simply Wall St 11h
Eli Lilly Stock Climbs On GLP 1 Strength And 86% Margin

Eli Lilly stock rose almost 5% today, even after a choppy week, as investors focused on one central idea. The earnings story is centered on profit power. Non GA...

Eli Lilly Stock Climbs On GLP 1 Strength And 86% Margin
TipRanks 14h
Eli Lilly Earnings Call Highlights Powerful Growth Momentum

Eli Lilly And Company ((LLY)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools...

Nasdaq 16h
Why Eli Lilly Stock Climbed Today

What happened Shares of Eli Lilly (NYSE: LLY) rose on Monday after the U.S. Food and Drug Administration (FDA) approved the pharmaceutical giant's new diabetes...

Why Eli Lilly Stock Climbed Today
Barron's 19h
Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Healthcare Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy. In this article XLV LLY VRTX GILD MCK Many healthcare and pharmaceutic...

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.
CNBC 19h
We're increasing our Eli Lilly price target after another beat-and-raise quarter

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company's portfolio of GLP-1 drugs continues to...

We're increasing our Eli Lilly price target after another beat-and-raise quarter

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.